If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
| pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
| 0 |
1
|
2
|
2
|
0 |
916
|
921
|
Gene and significance breakdown #
Total genes and gene combinations: 66
| Gene or gene combination |
likely pathogenic |
uncertain significance |
likely benign |
not provided |
total |
|
LOC102724058, SCN1A
|
0 |
1
|
0 |
106
|
107
|
|
SCN1A
|
0 |
1
|
0 |
85
|
86
|
|
NF1
|
0 |
0 |
0 |
73
|
73
|
|
CYBB
|
0 |
0 |
0 |
61
|
61
|
|
ARSA
|
0 |
0 |
0 |
60
|
60
|
|
F11
|
0 |
0 |
0 |
41
|
41
|
|
CACNA1A
|
0 |
0 |
1
|
38
|
39
|
|
OCRL
|
0 |
0 |
0 |
35
|
35
|
|
ADAMTS13
|
0 |
0 |
0 |
32
|
32
|
|
SLC37A4
|
0 |
0 |
0 |
32
|
32
|
|
SMARCA2
|
0 |
0 |
0 |
28
|
28
|
|
ADA
|
0 |
0 |
0 |
26
|
26
|
|
TPP1
|
0 |
0 |
0 |
23
|
23
|
|
DKC1
|
0 |
0 |
0 |
22
|
22
|
|
INS, INS-IGF2
|
0 |
0 |
1
|
20
|
21
|
|
RAG1
|
0 |
0 |
0 |
20
|
20
|
|
NCF2
|
0 |
0 |
0 |
17
|
17
|
|
AIRE
|
0 |
0 |
0 |
15
|
15
|
|
SERPING1
|
0 |
0 |
0 |
15
|
15
|
|
CARD14
|
0 |
0 |
0 |
13
|
13
|
|
IKBKG
|
0 |
0 |
0 |
10
|
10
|
|
ACTG1
|
0 |
0 |
0 |
9
|
9
|
|
ERCC8
|
0 |
0 |
0 |
7
|
7
|
|
SEMA3A
|
0 |
0 |
0 |
7
|
7
|
|
SLC46A1
|
0 |
0 |
0 |
7
|
7
|
|
SMAD4
|
0 |
0 |
0 |
7
|
7
|
|
CYBA
|
0 |
0 |
0 |
6
|
6
|
|
FREM1
|
0 |
0 |
0 |
6
|
6
|
|
MLC1
|
0 |
0 |
0 |
6
|
6
|
|
WDR11
|
0 |
0 |
0 |
6
|
6
|
|
CCBE1
|
0 |
0 |
0 |
5
|
5
|
|
CFHR5
|
0 |
0 |
0 |
5
|
5
|
|
SMARCA4
|
0 |
0 |
0 |
5
|
5
|
|
ACTB
|
0 |
0 |
0 |
4
|
4
|
|
GPR179
|
0 |
0 |
0 |
4
|
4
|
|
ITGB2
|
0 |
0 |
0 |
4
|
4
|
|
RAB7A
|
0 |
0 |
0 |
4
|
4
|
|
CARD14, SGSH
|
0 |
0 |
0 |
3
|
3
|
|
HAX1
|
0 |
0 |
0 |
3
|
3
|
|
LOC125446261, MLC1
|
0 |
0 |
0 |
3
|
3
|
|
PYCR1
|
0 |
0 |
0 |
3
|
3
|
|
SARM1, SLC46A1
|
0 |
0 |
0 |
3
|
3
|
|
TRPV3
|
0 |
0 |
0 |
3
|
3
|
|
WNT10A
|
0 |
0 |
0 |
3
|
3
|
|
ADA, LOC107303343
|
0 |
0 |
0 |
2
|
2
|
|
CACNA1A, LOC126862864
|
0 |
0 |
0 |
2
|
2
|
|
CBX2
|
0 |
0 |
0 |
2
|
2
|
|
CHST14
|
0 |
0 |
0 |
2
|
2
|
|
CYP26B1
|
0 |
0 |
0 |
2
|
2
|
|
ENPP1
|
0 |
0 |
0 |
2
|
2
|
|
HTRA1
|
0 |
0 |
0 |
2
|
2
|
|
RTTN
|
0 |
0 |
0 |
2
|
2
|
|
TACR3
|
0 |
0 |
0 |
2
|
2
|
|
VAPB
|
0 |
0 |
0 |
2
|
2
|
|
ABCD4
|
0 |
0 |
0 |
1
|
1
|
|
ADA, PKIG
|
0 |
0 |
0 |
1
|
1
|
|
ADAMTS13, LOC130002910
|
0 |
0 |
0 |
1
|
1
|
|
BMP1, LOC129999976
|
0 |
0 |
0 |
1
|
1
|
|
GFER
|
0 |
0 |
0 |
1
|
1
|
|
HCFC1
|
0 |
0 |
0 |
1
|
1
|
|
ITK
|
0 |
0 |
0 |
1
|
1
|
|
LOC126859653, SKIC2
|
0 |
0 |
0 |
1
|
1
|
|
MATR3
|
1
|
0 |
0 |
0 |
1
|
|
PRX
|
0 |
0 |
0 |
1
|
1
|
|
SLC33A1
|
0 |
0 |
0 |
1
|
1
|
|
TAC3
|
0 |
0 |
0 |
1
|
1
|
Condition and significance breakdown #
| Condition |
likely pathogenic |
uncertain significance |
likely benign |
not provided |
total |
|
not provided
|
0 |
0 |
2
|
534
|
536
|
|
Severe myoclonic epilepsy in infancy
|
0 |
0 |
0 |
150
|
150
|
|
Lowe syndrome
|
0 |
0 |
0 |
32
|
32
|
|
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency
|
0 |
0 |
0 |
29
|
29
|
|
Generalized epilepsy with febrile seizures plus, type 1
|
0 |
0 |
0 |
23
|
23
|
|
Dyskeratosis congenita, X-linked
|
0 |
0 |
0 |
22
|
22
|
|
Neuronal ceroid lipofuscinosis 2
|
0 |
0 |
0 |
22
|
22
|
|
Episodic ataxia type 2
|
0 |
0 |
0 |
20
|
20
|
|
Permanent neonatal diabetes mellitus
|
0 |
0 |
0 |
16
|
16
|
|
Migraine, familial hemiplegic, 1
|
0 |
0 |
0 |
15
|
15
|
|
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2
|
0 |
0 |
0 |
14
|
14
|
|
Hennekam lymphangiectasia-lymphedema syndrome 1
|
0 |
0 |
0 |
5
|
5
|
|
Generalized epilepsy
|
0 |
0 |
0 |
4
|
4
|
|
Migraine, familial hemiplegic, 3
|
0 |
0 |
0 |
4
|
4
|
|
Dent disease type 2
|
0 |
0 |
0 |
3
|
3
|
|
Focal epilepsy
|
0 |
0 |
0 |
3
|
3
|
|
Maturity-onset diabetes of the young type 10
|
0 |
0 |
0 |
3
|
3
|
|
46,XY sex reversal 5
|
0 |
0 |
0 |
2
|
2
|
|
Autism
|
0 |
2
|
0 |
0 |
2
|
|
CARASIL syndrome
|
0 |
0 |
0 |
2
|
2
|
|
Ehlers-Danlos syndrome, musculocontractural type
|
0 |
0 |
0 |
2
|
2
|
|
Hypophosphatemic rickets, autosomal recessive, 2
|
0 |
0 |
0 |
2
|
2
|
|
Spinocerebellar ataxia type 6
|
0 |
0 |
0 |
2
|
2
|
|
Amyotrophic lateral sclerosis type 21
|
1
|
0 |
0 |
0 |
1
|
|
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome
|
0 |
0 |
0 |
1
|
1
|
|
Generalized epilepsy with febrile seizures plus, type 2
|
0 |
0 |
0 |
1
|
1
|
|
Lymphoproliferative syndrome 1
|
0 |
0 |
0 |
1
|
1
|
|
Macrocephaly and epileptic encephalopathy
|
0 |
0 |
0 |
1
|
1
|
|
Myoclonic encephalopathy
|
0 |
0 |
0 |
1
|
1
|
|
Type 1 diabetes mellitus 2
|
0 |
0 |
0 |
1
|
1
|
|
West syndrome
|
0 |
0 |
0 |
1
|
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. The submitted information has not been verified.
If you have questions about the information contained on this
website, please see a health care professional.